Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern
The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
Full Article
Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern
NYTimes.com
0 shares
1 views
You might like
Related news coverage
COVID-19 antibody treatment clinical trial paused over potential safety concern
CBS News
Drugmaker Eli Lilly announced a temporary hold on its COVID-19 antibody therapy. The pause comes as a need for the treatment grows...
Advertisement
More coverage
Eli Lilly COVID-19 antibody trial paused due to safety concerns
WorldNews
El Lilly & Co. paused enrollment of participants in a clinical trial of its antibody treatment for COVID-19 due to a potential..
-
Eli Lilly's Coronavirus Antibody Treatment Trial Halted
Upworthy
-
Coronavirus treatment trials halted over safety concerns
CBS News
-
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
The Age
-
Eli Lilly: Clinical trial of COVID-19 antibody treatment paused for safety concern
FXstreet.com